TFSA Investors: 2 Growth Stocks That Can Turn $6,000 Into $15,000 by 2025

Beaten-down growth stocks such as WELL Health and Teladoc Health should be part of your TFSA portfolio watchlist at current prices.

| More on:

Growth stocks have experienced a massive decline in the last three months due to a variety of reasons that include the possibility of multiple interest rate hikes and steep valuations. But if you look at historical trends, every market crash offers investors an opportunity to buy quality businesses at a cheaper valuation.

Here, we look at two growth stocks in WELL Health (TSX:WELL) and Teladoc Health (NYSE:TDOC) that should be up for consideration as part of your TFSA portfolio right now. The contribution room for your TFSA stands at $6,000 for 2022. The registered account is ideal to hold growth stocks over the long term as any withdrawals from the TFSA are exempt from Canada Revenue Agency taxes.

WELL Health Technologies

Valued at a market cap of $857 million, WELL Health stock is down 57% from all-time highs. Despite the pullback, the stock has returned over 4,000% to investors since its IPO in 2016. The health-tech company has increased sales from $5.89 million in 2018 to $50.24 million in 2020.

Now, WELL Health stated it expects to announce record financial performance in Q4 of 2021 with an annualized revenue run-rate of more than $450 million and an annualized operating adjusted EBITDA run-rate of almost $100 million. Additionally, its total number of omni-channel patient visits in Q4 more than doubled year over year to 692,913.

A key reason for the company’s stellar top-line growth is its focus on accretive acquisitions. It acquired entities such as Circle Medical and Wisp in 2021 that will drive revenue higher in the upcoming quarters. Further, WELL is also on track to deliver US$43 million in free cash flow in 2021.

Analysts tracking WELL Health expect sales to touch $298 million in 2021 and rise by 63.4% to $488 million in 2022. So, WELL stock is trading at a forward price to sales multiple of less than two times which is really cheap.

Bay Street has a 12-month average price target of $11.2 for WELL stock, which is 170% above its current trading price.

Teladoc Health

Shares of Teladoc Health have declined by 77% from all-time highs, valuing the company at a market cap of US$10.8 billion. The COVID-19 pandemic increased demand for Teladoc’s suite of services at an accelerated pace, allowing it to almost double its sales. However, investors must also note that Teladoc increased sales at an annual rate of 74% in seven years prior to the pandemic.

There are some concerns over Teladoc’s ability to grow revenue in a post-pandemic world. But, in Q3 of 2021, online visits on the Teladoc platform rose by 37% year over year. Further, a report from Allied Market Research has estimated the global telehealth industry to touch US$430 billion by 2030, indicating annual growth rates of 25%.

Teladoc aims to grow sales at an annual rate of between 25% and 30% through 2024, allowing it to touch US$4 billion in sales by end of the forecast period.

At the current price, TDOC stock is valued at a forward price to sales multiple of four, which is quite reasonable. Wall Street expects TDOC stock to gain over 100% in the next 12-months to trade around US$141 per share.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool recommends Teladoc Health.

More on Tech Stocks

A data center engineer works on a laptop at a server farm.
Tech Stocks

3 No-Brainer Data Centre Stocks to Buy With $500 Right Now

Data centres are going to be a huge growth opportunity in the next decade. And these are the top buys.

Read more »

The virtual button with the letters AI in a circle hovering above a keyboard, about to be clicked by a cursor.
Tech Stocks

Is OpenText Stock a Buy, Sell, or Hold for 2025?

OpenText stock has fallen in the last few years, but that could mean this top tech stock remains an undervalued…

Read more »

AI microchip
Tech Stocks

Celestica Stock: Buy, Sell, or Hold?

Celestica's stock price has rallied 950% in the last five years. Will the AI boom send it even higher in…

Read more »

data analyze research
Tech Stocks

2 Ridiculously Cheap Growth Stocks to Buy Hand Over Fist in 2024

Well Health Technologies is a cheap growth stock to buy for its record-breaking results, massive revenue growth, and profitability.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

4 Reasons to Buy Kinaxis Stock Like There’s No Tomorrow

Kinaxis stock has a strong past. But there is even more to look forward to from this top tech stock.

Read more »

The letters AI glowing on a circuit board processor.
Tech Stocks

The Future of AI: Best Canadian Stocks to Buy Now

Here are two of the best AI-focused stocks in Canada that you can consider adding to your portfolio before it’s…

Read more »

TFSA (Tax-Free Savings Account) on wooden blocks and Canadian one hundred dollar bills.
Tech Stocks

2 TFSA Stocks to Buy Right Now With $7,000

Are you looking for growth stocks that can help you maximize the tax-free withdrawals of the TFSA? This article is…

Read more »

cloud computing
Tech Stocks

3 No-Brainer Tech Stocks to Buy Right Now for Less Than $1,000

Not all tech stocks are the risky investments that many think they are. Which is why we're focusing on the…

Read more »